[Indicators of immunologic reactivity in children with chronic laryngostenosis]. 1990

E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova

Immunological examinations of 40 children with papillomatosis and chronic cicatricial stenosis of the larynx included measurements of circulating immune complexes (CIC) and lysozyme in the saliva and serum as well as complement activity in serum. The examinations were performed regularly during treatment. It was found that immunobiological factors played an important part in the pathogenesis of papillomatosis and cicatricial stenosis of the larynx in children. It was shown that CIC and lysozyme concentrations in the saliva and serum as well as complement activity in serum increased. In the course of treatment all the groups displayed an increase of lysozyme in the saliva; patients with papillomatosis showed a decrease of the CIC concentration and those with cicatricial stenosis a decline of complement activity in serum. Involvement of the autoimmune component in the pathogenesis of the above diseases is discussed. Applicability of the results for controlling the therapeutic efficacy and predicting the outcome of diseases is considered.

UI MeSH Term Description Entries
D007822 Laryngeal Neoplasms Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS. Cancer of Larynx,Laryngeal Cancer,Larynx Neoplasms,Cancer of the Larynx,Larynx Cancer,Neoplasms, Laryngeal,Cancer, Laryngeal,Cancer, Larynx,Cancers, Laryngeal,Cancers, Larynx,Laryngeal Cancers,Laryngeal Neoplasm,Larynx Cancers,Larynx Neoplasm,Neoplasm, Laryngeal,Neoplasm, Larynx,Neoplasms, Larynx
D007829 Laryngostenosis Developmental or acquired stricture or narrowing of the LARYNX. Symptoms of respiratory difficulty depend on the degree of laryngeal narrowing. Laryngeal Stenosis,Acquired Laryngeal Stenosis,Acquired Subglottic Stenosis,Congenital Subglottic Stenosis,Acquired Laryngeal Stenoses,Acquired Subglottic Stenoses,Congenital Subglottic Stenoses,Laryngeal Stenoses,Laryngeal Stenoses, Acquired,Laryngeal Stenosis, Acquired,Laryngostenoses,Stenoses, Acquired Laryngeal,Stenoses, Acquired Subglottic,Stenoses, Congenital Subglottic,Stenoses, Laryngeal,Stenosis, Acquired Laryngeal,Stenosis, Acquired Subglottic,Stenosis, Congenital Subglottic,Stenosis, Laryngeal,Subglottic Stenoses, Acquired,Subglottic Stenoses, Congenital,Subglottic Stenosis, Acquired,Subglottic Stenosis, Congenital
D008297 Male Males
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D010212 Papilloma A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed) Papilloma, Squamous Cell,Papillomatosis,Papillomas,Papillomas, Squamous Cell,Papillomatoses,Squamous Cell Papilloma,Squamous Cell Papillomas
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D005260 Female Females

Related Publications

E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
August 1986, Vestnik khirurgii imeni I. I. Grekova,
E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
January 1977, Zhurnal ushnykh, nosovykh i gorlovykh boleznei = The journal of otology, rhinology, and laryngologie [sic],
E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
January 1969, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
July 1985, Gematologiia i transfuziologiia,
E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
July 1975, Voprosy okhrany materinstva i detstva,
E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
September 1973, Pediatriia,
E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
March 1986, Gematologiia i transfuziologiia,
E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
January 1972, Grudnaia khirurgiia (Moscow, Russia),
E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
July 1974, Monatsschrift fur Kinderheilkunde,
E A Tsvetkov, and L M Ishchenko, and I V Savenko, and S N Agadzhanova
January 1975, Terapevticheskii arkhiv,
Copied contents to your clipboard!